Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00101868 · ClinicalTrials.gov registry record · NA

Value of Technology to Transfer Discharge Information

A NA study, sponsored by Agency for Healthcare Research and Quality (AHRQ).

Completed
Registry status
NA
Development phase
631
Enrollment target

NCT00101868: Completed NA study, sponsored by Agency for Healthcare Research and Quality (AHRQ).

NCT00101868 is a NA study that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 631 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00101868, a NA study, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).

COMPLETED
Registry status
NA
Development phase
631 participants
Enrollment target

Study Summary

The transition from hospital to home is a high-risk period in a patient's illness. Poor communication between healthcare providers at hospital discharge is common and contributes to adverse events affecting patients after discharge. The importance of good communication at discharge will increase as more primary care providers delegate inpatient care to hospitalists. Any process that improves information transfer among providers at discharge might improve the health and safety of patients discharged from U.S. hospitals each year, and to appreciably reduce unnecessary healthcare expenditures. Information transfer among healthcare providers and their patients can be undermined because of inaccuracies, omissions, illegibility, logistical failure (e.g., information is never delivered), and delays in generation (i.e., dictation or transcription) or transmission. Root causes include recall error, increased physician workloads, interface failures (e.g., physician-clerical) and poor training of physicians in the discharge process. Many of the deficiencies in the current process of information transfer at hospital discharge could be effectively addressed by the application of information technology. The proposed study will measure the value of a software application to facilitate information transfer at hospital discharge. The study is designed to compare the benefits of discharge health information technology versus usual care in high-risk patients recently discharged from acute care hospitalization. The design is a randomized, single-blind, controlled trial. The outcomes are readmission within 6 months, adverse events, and effectiveness and satisfaction with the discharge process from the patient and physician perspectives. The cost outcome is the physician time required to use the discharge software.

Primary Outcome

Number of participants with at least one readmission within 6 months after discharge from index hospital visit

Interventions

  • DEVICE Discharge communication software
  • OTHER Usual care discharge process

Trial Details

FieldValue
Enrollment Target 631 participants
Start Date 2004-12
Est. Completion 2007-08
Phase NA

What the finished NCT00101868 record still lists

NCT00101868 is an interventional study that assigns participants to a tested intervention. The registered 631 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).

The record links to 0 conditions, and to 2 interventions - of which Discharge communication software is the first listed.

NCT00101868 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00101868 about?

NCT00101868 is a clinical study titled "Value of Technology to Transfer Discharge Information". The transition from hospital to home is a high-risk period in a patient's illness. Poor communication between healthcare providers at hospital discharge is common and contributes to adverse events affecting patients after discharge. The importance of good communication at discharge will increase as ...

What is the current status of trial NCT00101868?

This trial is currently completed. It is a NA study. The enrollment target is 631 participants. The study started on 2004-12. Estimated completion is 2007-08.

What interventions are being tested in trial NCT00101868?

The interventions under investigation include: Discharge communication software (DEVICE), Usual care discharge process (OTHER).

Who is sponsoring clinical trial NCT00101868?

This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00101868's enrollment target sits among peer trials

631 159th of 2000 higher than 1,842 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05744973 · 631 participants

    Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families

  • NCT04704921 · 630 participants · Phase 2

    Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

  • NCT04707729 · 630 participants · NA

    ROX Index for the Timing of Intubation in Nasal High Flow

  • NCT05061550 · 630 participants · Phase 2

    Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00101868, the US trial registry maintained by the National Library of Medicine. NCT00101868 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.